1. Home
  2. ALMR vs PLUS Comparison

ALMR vs PLUS Comparison

Compare ALMR & PLUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alamar Biosciences Inc. Common Stock

ALMR

Alamar Biosciences Inc. Common Stock

N/A

Current Price

$28.64

Market Cap

2.1B

Sector

Industrials

ML Signal

N/A

Logo ePlus inc.

PLUS

ePlus inc.

N/A

Current Price

$95.71

Market Cap

2.5B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
ALMR
PLUS
Founded
2018
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Retail: Computer Software & Peripheral Equipment
Sector
Industrials
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.5B
IPO Year
2026
1996

Fundamental Metrics

Financial Performance
Metric
ALMR
PLUS
Price
$28.64
$95.71
Analyst Decision
Buy
Analyst Count
5
0
Target Price
★ $37.00
N/A
AVG Volume (30 Days)
★ 674.6K
192.5K
Earning Date
11-03-2026
11-05-2026
Dividend Yield
N/A
★ 1.11%
EPS Growth
N/A
★ 24.20
EPS
N/A
★ 2.72
Revenue
N/A
★ $2,442,549,000.00
Revenue This Year
$64.80
$4.67
Revenue Next Year
$37.27
$4.89
P/E Ratio
★ N/A
$35.49
Revenue Growth
N/A
★ 18.07
52 Week Low
$21.58
$73.09
52 Week High
$39.61
$99.64

Technical Indicators

Market Signals
Indicator
ALMR
PLUS
Relative Strength Index (RSI) 45.59 53.71
Support Level $23.87 $84.98
Resistance Level $29.06 $97.08
Average True Range (ATR) 2.38 4.06
MACD -0.06 0.31
Stochastic Oscillator 47.77 81.12

Price Performance

Historical Comparison
ALMR
PLUS

About ALMR Alamar Biosciences Inc. Common Stock

Alamar Biosciences Inc is a proteomics company engaged in protein detection and analysis. The company has developed its own NULISA (NUcleic Acid Linked Immuno-Sandwich Assay) technology as the foundation of its Precision Proteomics platform enabling the detection and quantification of protein biomarkers in a single sample with ultra-high sensitivity and high specificity, even from very small volumes of biofluid. The company operates in single segment and focuses on developing a good sensitive proteomic liquid biopsy platform and sells instruments, consumables, and services based on this platform to enable early detection of diseases. The products of the company includes NULISAseq Panels, NULISAqpcr Assays, and others.

About PLUS ePlus inc.

ePlus Inc is a provider of technology solutions across the IT spectrum, spanning security, cloud, data center, networking, collaboration, AI, service provider, and critical infrastructure, and emerging solutions, to domestic and foreign organizations across all industry segments. Its solutions leverage a broad range of professional, consultative, and managed services across the technology spectrum. The company possesses top-level engineering certifications with a broad range of IT technologies that enable the company to offer multi-vendor IT solutions that are optimized for each of its customers' specific requirements. It also offers a wide portfolio of technology and other capital asset financing solutions to customers across commercial and government enterprises, designing programs.

Share on Social Networks: